APA (7th ed.) Citation

Hillemanns, P., Zikan, M., Forget, F., Denys, H. G., Baurain, J., Rob, L., . . . Lindemann, K. (2025). Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer: A multicenter, single-arm phase 2a study. Journal for ImmunoTherapy of Cancer, 13(1), . https://doi.org/10.1136/jitc-2024-010827

Chicago Style (17th ed.) Citation

Hillemanns, Peter, et al. "Safety and Efficacy of the Therapeutic DNA-based Vaccine VB10.16 in Combination with Atezolizumab in Persistent, Recurrent or Metastatic HPV16-positive Cervical Cancer: A Multicenter, Single-arm Phase 2a Study." Journal for ImmunoTherapy of Cancer 13, no. 1 (2025). https://doi.org/10.1136/jitc-2024-010827.

MLA (9th ed.) Citation

Hillemanns, Peter, et al. "Safety and Efficacy of the Therapeutic DNA-based Vaccine VB10.16 in Combination with Atezolizumab in Persistent, Recurrent or Metastatic HPV16-positive Cervical Cancer: A Multicenter, Single-arm Phase 2a Study." Journal for ImmunoTherapy of Cancer, vol. 13, no. 1, 2025, https://doi.org/10.1136/jitc-2024-010827.